Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Middle East Healthcare CoSAU:4009 +0.24%80 5-Year Yield-on-Cost % is 1.53 as of Sep. 01, 2026, which is 55% below its 10-year median of 3.42. GuruFocus rates SAU:4009 with a GF Score™ of 80/100 and a GF Value™ of ﷼77.05 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 280 Healthcare Providers & Services companies, Middle East Healthcare Co ranks worse than 71.07% on this metric.
The historical rank and industry rank for Middle East Healthcare Co's 5-Year Yield-on-Cost % or its related term are showing as below:
SAU:4009'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.85 Med: 3.42 Max: 7.72
Current: 1.53
During the past 11 years, Middle East Healthcare Co's highest Yield on Cost was 7.72. The lowest was 0.85. And the median was 3.42.
SAU:4009's 5-Year Yield-on-Cost % is ranked worse than 71.07% of 280
companies
in the Healthcare Providers & Services industry
Industry Median: 2.915
vs SAU:4009: 1.53
Middle East Healthcare Co (SAU:4009) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Middle East Healthcare Co 5-Year Yield-on-Cost % Related Terms
SAU:4009 vs HCA, THC, EHC: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Middle East Healthcare Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Middle East Healthcare Co 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Middle East Healthcare Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Middle East Healthcare Co's 5-Year Yield-on-Cost % falls into.
Middle East Healthcare Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Middle East Healthcare Co (SAU:4009) has a 5-Year Yield-on-Cost % of 1.53 as of Sep. 01, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Middle East Healthcare Co and its competitors. This is 55% below median its historical median of 3.42. Over the past decade, Middle East Healthcare Co's 5-Year Yield-on-Cost % has ranged from 0.85 to 7.72. According to the industry distribution chart, Middle East Healthcare Co ranks #199 out of 280 companies in the Healthcare Providers & Services industry, placing it in the top 71.1%.
Is Middle East Healthcare Co's 5-Year Yield-on-Cost % too high?
Middle East Healthcare Co's current 5-Year Yield-on-Cost % of 1.53 is 55% below median its 10-year median of 3.42. Over the past 10 years, this metric has ranged from a low of 0.85 to a high of 7.72. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.92. Middle East Healthcare Co's value of 1.53 is 47.5% below this industry median. Based on the distribution chart, Middle East Healthcare Co ranks #199 out of 280 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Middle East Healthcare Co has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Middle East Healthcare Co's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Middle East Healthcare Co ranks #199 out of 280 companies for 5-Year Yield-on-Cost %. This places Middle East Healthcare Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.92. Middle East Healthcare Co's value of 1.53 is 47.5% below this benchmark. Historically, Middle East Healthcare Co's own 5-Year Yield-on-Cost % has ranged from 0.85 to 7.72 over the past decade. While the company's 10-year median is 3.42 vs. the industry median of 2.92, Middle East Healthcare Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.92, based on 280 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Middle East Healthcare Co's current 5-Year Yield-on-Cost % of 1.53 is 47.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Middle East Healthcare Co and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Middle East Healthcare Co's current 5-Year Yield-on-Cost % is 1.53, which is 55% below median its own 10-year median of 3.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Middle East Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Middle East Healthcare Co (SAU:4009) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼77.05, compared to a current price of ﷼32.96 — trading 57.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 1.53, which is 55% below median its 10-year median of 3.42 and 47.5% below the Healthcare Providers & Services industry median of 2.92. Middle East Healthcare Co's overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Middle East Healthcare Co (SAU:4009), the current 5-Year Yield-on-Cost % is 1.53 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Middle East Healthcare Co (SAU:4009) Overvalued in 2026?
Based on GuruFocus' analysis, Middle East Healthcare Co stock appears to be undervalued.
The current stock price of ﷼32.96 is trading 57.2% below its estimated GF Value™ of ﷼77.05.
GuruFocus considers Middle East Healthcare Co to be Possible Value Trap.
Key valuation signals for SAU:4009:
5-Year Yield-on-Cost %: 1.53 (55% below median its 10-year median of 3.42)
GF Value™: ﷼77.05 vs. price of ﷼32.96 (57.2% below fair value)
Industry Position: 47.5% below the Healthcare Providers & Services median (#199 of 280)
No single metric tells the full story. See the SAU:4009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Middle East Healthcare Co is a Saudi Arabia-based company engaged in the business of managing, operating and maintaining hospitals, medical centers, educational centers, rehabilitation centers, physiotherapy, laboratories and radiology centers, pharmacies, construction, and to buy land for the purpose of constructing medical projects and to establish, manage and organize exhibitions for the company. The company's reportable segments are Inpatient Services, Outpatient Services, Pharmacy Sales and Others. The majority of revenue is derived from the Inpatient Services segment.
80GF Score
Get the complete analysis for SAU:4009
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4009 has been successfully added to your 
